Most Americans would prefer brand-name drugs—but end up buying generic versions because of the cost, new consumer research ...

The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.

Public anger in China over concerns raised by doctors that generic drugs used in public hospitals are increasingly ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

A 2015 study by Harvard Business Publishing Education revealed that Telma was introduced by Glenmark in 2003 at a time when ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

India's pharma market has introduced 3,151 new brands in the past year, with AstraZeneca's cancer drug Enhertu becoming the ...

Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.